CXCL8 and cystic fibrosis: Rescue of Phe508del-CFTR and antagonism of LPA2 attenuate the IL-8 release from CFBEo−-Phe508del-CFTR cells, which could suppress the initiation of inflammatory response in CF and therefore inhibit the excessive infiltration of neutrophils and the subsequent inflammation.